 This is a randomized, doubleblind, placebocontrolled, single ascending dose study conducted at one study center in the United States. Six 6 cohorts of 8 subjects each 6 active and 2 placebo, with one cohort crossing over to assess food effect, are planned for evaluation. Subjects will participate in only one cohort. 